Developer docs
API playgroundTry for free, no card

Search company profiles

Diteba

Full company profile

uuid000g7k2

Namestring
Diteba
Legal namestring
Diteba Inc.
Websiteurl
diteba.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Diteba Inc. is a privately held contract research organization (CRO) founded in 2004 and headquartered in a 27,000 sq ft GMP/GLP-compliant laboratory facility in Mississauga, Ontario, Canada. The company delivers analytical and bioanalytical testing services to pharmaceutical and nutraceutical clients across the full drug development lifecycle, from early R&D method development through commercial and post-approval stability studies. Its service portfolio spans nine interconnected lines: Analytical Services, Bioanalytical Services, Biologics (oligonucleotides, peptides, proteins, polysaccharides), In Vitro Release Testing (IVRT) and In Vitro Permeation Testing (IVPT) for topical and transdermal products, QC Release Testing, Stability Testing, GMO Testing via Droplet Digital PCR, and Omega-3 Testing.

The laboratory is equipped with Waters chromatography (Alliance 2690 HPLC, ACQUITY UPLC), Waters mass spectrometry systems (ACQUITY TQD, Xevo TQ-S, QToF MS), ELISA-based bioanalytical platforms, Franz Cell and Enhanced Cell IVRT/IVPT systems, and a Waters NuGenesis SDMS data management environment with electronic audit trails. The facility features dual-laboratory redundancy, gas-powered generator and UPS backup, and a fully validated environmental monitoring system supporting continuous long-duration stability studies. Diteba is licensed by Health Canada (DEL, Controlled Substance Licence, Precursor Licence), registered with the FDA (inspected 2019, remotely audited 2023), compliant with EMA and ICH guidelines, and pursuing ISO 17025 accreditation.

Diteba generates revenue on a project-based, quote-driven professional services model, with pricing determined by service scope, regulatory complexity, sample volume, and contract duration, including multi-year stability and bioequivalence programs. Customers engage directly via phone, email, and sample submission, with services delivered globally to pharmaceutical and nutraceutical companies seeking FDA, Health Canada, and EMA-aligned testing and regulatory support. The company has stated it has supported "hundreds of companies" in navigating FDA approval over 20+ years and holds a documented FDA Bioequivalence approval for Penciclovir Cream 1% via an IVPT study.

Short descriptiontext

Diteba is a privately held Canadian contract research organization founded in 2004 that provides GMP/GLP-compliant analytical, bioanalytical, IVRT/IVPT, biologics, stability, and QC testing services to pharmaceutical and nutraceutical companies seeking FDA, Health Canada, and EMA regulatory support.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMississauga, Canada
HQ citystring
Mississauga
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
analytical testing services, bioanalytical testing, pharmaceutical contract research, stability testing, nutraceutical testing
Industry3 codes
PRIMARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)
NAICS code3 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences54171
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Contract Research Organization (CRO) / Pharmaceutical Testing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research and Testing Services
TypeProfessional Services
Description

Diteba generates revenue through providing specialized analytical and bioanalytical testing services on a contract/project basis. Services include method development, validation, sample analysis, stability testing, QC release testing, and specialized testing (IVRT, IVPT, GMO, Omega-3). Revenue is project-based with pricing determined by scope, complexity, and regulatory requirements.

diteba.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales
Pricing details1 tier
1Custom project-based pricing based on service scope
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing determined by specific testing requirements, sample quantities, regulatory compliance needs, and project complexity. Contact-based engagement with personalized quotes.

diteba.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Diteba is a contract research organization (CRO) that provides analytical and bioanalytical testing services to pharmaceutical and nutraceutical companies. Services include method development and validation, stability testing, QC release testing, bioequivalence studies, and specialized topical formulation testing (IVRT/IVPT) at a 27,000 sq ft GMP/GLP-compliant laboratory in Mississauga, Ontario. The company supports drug development from early R&D through commercial and post-approval stages under FDA, Health Canada, EMA, and ICH regulatory frameworks.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Successfully assisted pharmaceutical clients with ANDA submissions through IVRT and IVPT expertise with FDA approval for Penciclovir Cream 1% IVPT study
+1 more record
Product overview1 text field

Diteba is a pharmaceutical and nutraceutical contract research organization (CRO) providing analytical and bioanalytical testing services. The company operates a 27,000 square foot GMP/GLP-compliant laboratory facility in Mississauga, Ontario, Canada. Their service portfolio is organized as distinct but interconnected testing service lines covering the full drug development lifecycle: Analytical Services and Bioanalytical Services serve as the core offerings, supplemented by specialized services including Biologics (for large molecules), IVRT/IVPT (for topical drug products), QC Release Testing, Stability Testing, GMO Testing, and Omega-3 Testing. Services are delivered under cGMP/cGLP compliance with FDA, Health Canada, EMA, and ICH regulatory frameworks. The company also provides regulatory support for FDA and Health Canada submissions.

Product and service9 records
1Analytical Services
CategoryCore Service
Description

Comprehensive analytical testing services supporting small and large molecule drug substance and product analysis, including method development, validation, stability programs, IVRT/IVPT studies, wet chemistry testing, dissolution tests, method transfer, and residual solvent testing for pharmaceutical and nutraceutical companies.

2Bioanalytical Services
3Biologics Services
4In Vitro Release Testing (IVRT)
5In Vitro Permeation Testing (IVPT)
6QC Release Testing
7Stability Testing
8GMO Testing
9Omega-3 Testing
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major CRO offering bioanalytical, preclinical, and manufacturing services. Comparable because Charles River competes in the same bioanalytical/biopharmaceutical testing space that Diteba serves, but with significantly broader capabilities and global footprint.

TypeBroad incumbent
Description

Global testing services provider with pharmaceutical and nutraceutical testing capabilities. Comparable because SGS offers pharmaceutical analytical testing, nutraceutical quality testing, GMO testing, and Omega-3 testing services that overlap with Diteba's portfolio.

TypeBroad incumbent
Description

World's largest clinical research services and biopharmaceutical analytics provider. Comparable because IQVIA's laboratory services arm competes in the central lab and bioanalytical testing markets that Diteba serves, though IQVIA offers much broader clinical and data services.

TypeBroad incumbent
Description

Global quality assurance and testing provider with pharmaceutical and nutraceutical laboratory services. Comparable because Intertek offers analytical testing, stability, GMP release, and nutraceutical testing that directly overlaps Diteba's service portfolio.

TypeBroad incumbent
Description

Global CRO/CDMO providing laboratory testing, bioanalytical, and biologics services. Comparable as a broader incumbent competing in Diteba's analytical and biologics testing space, but with much wider capabilities across discovery, development, and manufacturing.

TypeBroad incumbent
Description

Global leader in bioanalytical, pharmaceutical, and clinical testing services. Comparable because Eurofins competes directly with Diteba in pharmaceutical analytical testing, bioequivalence, and stability studies, but at vastly greater scale and across a broader service portfolio.

TypeDirect peer
Description

Canadian-headquartered CRO providing bioanalytical, preclinical, and clinical research services. Comparable as a direct peer and regional competitor offering overlapping bioanalytical and bioequivalence services from Canada to similar pharma client segments.

TypeBroad incumbent
Description

Major CRO and central laboratory operator with bioanalytical and bioequivalence service lines. Comparable because Labcorp's early development services overlap with Diteba's bioanalytical and analytical testing, including bioequivalence work for generic drugs.

TypeDirect peer
Description

Specialty CRO focused on bioanalytical and drug metabolism services. Comparable as a direct peer because BASi provides small- and large-molecule bioanalytical testing, PK studies, and contract research services to pharmaceutical clients in a similar niche to Diteba.

TypeDirect peer
Description

Early-phase clinical and bioanalytical CRO specializing in PK/PD, bioequivalence, and first-in-human studies. Comparable because Celerion operates in the same bioanalytical and bioequivalence testing niche that Diteba serves, particularly for generic drug programs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Diteba

Contract Research Organization (CRO) / Pharmaceutical Testing Servicesditeba.com

Diteba is a privately held Canadian contract research organization founded in 2004 that provides GMP/GLP-compliant analytical, bioanalytical, IVRT/IVPT, biologics, stability, and QC testing services to pharmaceutical and nutraceutical companies seeking FDA, Health Canada, and EMA regulatory support.

What Diteba does

Diteba Inc. is a privately held contract research organization (CRO) founded in 2004 and headquartered in a 27,000 sq ft GMP/GLP-compliant laboratory facility in Mississauga, Ontario, Canada. The company delivers analytical and bioanalytical testing services to pharmaceutical and nutraceutical clients across the full drug development lifecycle, from early R&D method development through commercial and post-approval stability studies. Its service portfolio spans nine interconnected lines: Analytical Services, Bioanalytical Services, Biologics (oligonucleotides, peptides, proteins, polysaccharides), In Vitro Release Testing (IVRT) and In Vitro Permeation Testing (IVPT) for topical and transdermal products, QC Release Testing, Stability Testing, GMO Testing via Droplet Digital PCR, and Omega-3 Testing.

The laboratory is equipped with Waters chromatography (Alliance 2690 HPLC, ACQUITY UPLC), Waters mass spectrometry systems (ACQUITY TQD, Xevo TQ-S, QToF MS), ELISA-based bioanalytical platforms, Franz Cell and Enhanced Cell IVRT/IVPT systems, and a Waters NuGenesis SDMS data management environment with electronic audit trails. The facility features dual-laboratory redundancy, gas-powered generator and UPS backup, and a fully validated environmental monitoring system supporting continuous long-duration stability studies. Diteba is licensed by Health Canada (DEL, Controlled Substance Licence, Precursor Licence), registered with the FDA (inspected 2019, remotely audited 2023), compliant with EMA and ICH guidelines, and pursuing ISO 17025 accreditation.

Diteba generates revenue on a project-based, quote-driven professional services model, with pricing determined by service scope, regulatory complexity, sample volume, and contract duration, including multi-year stability and bioequivalence programs. Customers engage directly via phone, email, and sample submission, with services delivered globally to pharmaceutical and nutraceutical companies seeking FDA, Health Canada, and EMA-aligned testing and regulatory support. The company has stated it has supported "hundreds of companies" in navigating FDA approval over 20+ years and holds a documented FDA Bioequivalence approval for Penciclovir Cream 1% via an IVPT study.

Diteba firmographics

Firmographics
Name
Diteba
Legal name
Diteba Inc.
Website
https://diteba.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Diteba is a privately held Canadian contract research organization founded in 2004 that provides GMP/GLP-compliant analytical, bioanalytical, IVRT/IVPT, biologics, stability, and QC testing services to pharmaceutical and nutraceutical companies seeking FDA, Health Canada, and EMA regulatory support.
Ownership category
akta.pro rank

Diteba industry classification

Industry
Product category
Contract Research Organization (CRO) / Pharmaceutical Testing Services
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAAAE
Central Laboratory & Clinical Trial Testing CROs
SECONDARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAA
Clinical CROs (Phase I–IV)

Keywords

  • Analytical testing services
  • Bioanalytical testing
  • Pharmaceutical contract research
  • Stability testing
  • Nutraceutical testing

Where Diteba is headquartered

Location

Headquarters

HQ city
Mississauga
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Diteba business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Infrastructure, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. Contract Research and Testing Services: Diteba generates revenue through providing specialized analytical and bioanalytical testing services on a contract/project basis. Services include method development, validation, sample analysis, stability testing, QC release testing, and specialized testing (IVRT, IVPT, GMO, Omega-3). Revenue is project-based with pricing determined by scope, complexity, and regulatory requirements.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing based on service scope

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Diteba product offering

Product offering

Core offering

Diteba is a contract research organization (CRO) that provides analytical and bioanalytical testing services to pharmaceutical and nutraceutical companies. Services include method development and validation, stability testing, QC release testing, bioequivalence studies, and specialized topical formulation testing (IVRT/IVPT) at a 27,000 sq ft GMP/GLP-compliant laboratory in Mississauga, Ontario. The company supports drug development from early R&D through commercial and post-approval stages under FDA, Health Canada, EMA, and ICH regulatory frameworks.

Product overview

Diteba is a pharmaceutical and nutraceutical contract research organization (CRO) providing analytical and bioanalytical testing services. The company operates a 27,000 square foot GMP/GLP-compliant laboratory facility in Mississauga, Ontario, Canada. Their service portfolio is organized as distinct but interconnected testing service lines covering the full drug development lifecycle: Analytical Services and Bioanalytical Services serve as the core offerings, supplemented by specialized services including Biologics (for large molecules), IVRT/IVPT (for topical drug products), QC Release Testing, Stability Testing, GMO Testing, and Omega-3 Testing. Services are delivered under cGMP/cGLP compliance with FDA, Health Canada, EMA, and ICH regulatory frameworks. The company also provides regulatory support for FDA and Health Canada submissions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Analytical Services Comprehensive analytical testing services supporting small and large molecule drug substance and product analysis, including method development, validation, stability programs, IVRT/IVPT studies, wet chemistry testing, dissolution tests, method transfer, and residual solvent testing for pharmaceutical and nutraceutical companies.
  • Bioanalytical Services
  • Biologics Services
  • In Vitro Release Testing (IVRT)
  • In Vitro Permeation Testing (IVPT)
  • QC Release Testing
  • Stability Testing
  • GMO Testing
  • Omega-3 Testing

Quantifiable outcome

  • Successfully assisted pharmaceutical clients with ANDA submissions through IVRT and IVPT expertise with FDA approval for Penciclovir Cream 1% IVPT study
  • +1 more outcomes

Companies that use Diteba

Customer profile

Segments3 records

Ideal customer profiles3 records

Diteba technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature6 records

Diteba partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves4 records

Expansion highlights5 records

Diteba competitors and assessment

Company assessment

Broad incumbents

  • Charles River Laboratories: Major CRO offering bioanalytical, preclinical, and manufacturing services. Comparable because Charles River competes in the same bioanalytical/biopharmaceutical testing space that Diteba serves, but with significantly broader capabilities and global footprint.
  • SGS Health & Nutrition: Global testing services provider with pharmaceutical and nutraceutical testing capabilities. Comparable because SGS offers pharmaceutical analytical testing, nutraceutical quality testing, GMO testing, and Omega-3 testing services that overlap with Diteba's portfolio.
  • IQVIA: World's largest clinical research services and biopharmaceutical analytics provider. Comparable because IQVIA's laboratory services arm competes in the central lab and bioanalytical testing markets that Diteba serves, though IQVIA offers much broader clinical and data services.
  • Intertek Pharmaceutical Services: Global quality assurance and testing provider with pharmaceutical and nutraceutical laboratory services. Comparable because Intertek offers analytical testing, stability, GMP release, and nutraceutical testing that directly overlaps Diteba's service portfolio.
  • WuXi AppTec: Global CRO/CDMO providing laboratory testing, bioanalytical, and biologics services. Comparable as a broader incumbent competing in Diteba's analytical and biologics testing space, but with much wider capabilities across discovery, development, and manufacturing.
  • Eurofins Scientific: Global leader in bioanalytical, pharmaceutical, and clinical testing services. Comparable because Eurofins competes directly with Diteba in pharmaceutical analytical testing, bioequivalence, and stability studies, but at vastly greater scale and across a broader service portfolio.
  • Labcorp Drug Development (Covance): Major CRO and central laboratory operator with bioanalytical and bioequivalence service lines. Comparable because Labcorp's early development services overlap with Diteba's bioanalytical and analytical testing, including bioequivalence work for generic drugs.

Direct peers

  • Altasciences: Canadian-headquartered CRO providing bioanalytical, preclinical, and clinical research services. Comparable as a direct peer and regional competitor offering overlapping bioanalytical and bioequivalence services from Canada to similar pharma client segments.
  • Bioanalytical Systems Inc. (BASi): Specialty CRO focused on bioanalytical and drug metabolism services. Comparable as a direct peer because BASi provides small- and large-molecule bioanalytical testing, PK studies, and contract research services to pharmaceutical clients in a similar niche to Diteba.
  • Celerion: Early-phase clinical and bioanalytical CRO specializing in PK/PD, bioequivalence, and first-in-human studies. Comparable because Celerion operates in the same bioanalytical and bioequivalence testing niche that Diteba serves, particularly for generic drug programs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Diteba social profiles

Digital presence

Diteba compliance and trust

Trust signal

Compliance4 records

Diteba financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Diteba leadership team

Management profile

Number of profiles

Profiles1 record

Diteba funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Diteba M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Diteba

What does Diteba do?

Diteba is a contract research organization (CRO) that provides analytical and bioanalytical testing services to pharmaceutical and nutraceutical companies. Services include method development and validation, stability testing, QC release testing, bioequivalence studies, and specialized topical formulation testing (IVRT/IVPT) at a 27,000 sq ft GMP/GLP-compliant laboratory in Mississauga, Ontario. The company supports drug development from early R&D through commercial and post-approval stages under FDA, Health Canada, EMA, and ICH regulatory frameworks.

Is Diteba a public or private company?

Diteba is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Diteba founded?

Diteba was founded in 2004. It employs 11 to 50 people.

Where is Diteba based?

Diteba is headquartered in Mississauga, Canada, in the North America region.

How does Diteba make money?

One revenue line is on record: contract Research and Testing Services.

Who are Diteba's main competitors?

Broad incumbents on record are Charles River Laboratories, SGS Health & Nutrition, IQVIA, Intertek Pharmaceutical Services, WuXi AppTec, Eurofins Scientific and Labcorp Drug Development (Covance). Direct peers are Altasciences, Bioanalytical Systems Inc. (BASi) and Celerion.

Does Diteba have an API?

No public API is recorded for Diteba.

What industry is Diteba in?

Diteba's product category is Contract Research Organization (CRO) / Pharmaceutical Testing Services. Its primary akta.pro industry code is HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs, with a secondary code of HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals